Lyell Immunopharma to participate in Goldman Sachs, Stifel and Jefferies investor events

LYEL•2026-11-02

Lyell Immunopharma will participate in investor events hosted by Goldman Sachs on Nov. 5, Stifel on Nov. 10 and Jefferies on Nov. 18, 2026.

1. Investor events

Lyell Immunopharma will join a Goldman Sachs RxChange fireside chat on lymphoma CAR-T data on Nov. 5, 2026, at 11 a.m. ET. Management will take part in a Stifel Healthcare Conference fireside chat and one-on-one meetings on Nov. 10, and the team will attend one-on-one meetings at the Jefferies Global Healthcare Conference on Nov. 18.

Lyell Immunopharma to participate in Goldman Sachs, Stifel and Jefferies investor events

1. Investor events

Related News

Jaguar Health reports crofelemer reduces parenteral support needs in pediatric intestinal failure studies

Kimberly-Clark completes acquisition of Kenvue

Abeona Therapeutics announces new employee inducement grants under Nasdaq Listing Rule 5635(C)(4)

Quantum X Labs announces cyber quantum encryption breakthrough in demonstration with IBM quantum processor, Heron R2

XPEL showcases vehicle protection products at SEMA Show